NNVC
NANOVIRICIDES, INC.
Key Financials
Operating Income
$-9591645
↓ 12.6%
Revenue
$0
N/A
Net Income
$-9466966
↓ 14.1%
Total Assets
$8.8M
↓ 31.2%
EPS (Diluted)
$-0.63
↑ 10.0%
Shareholders' Equity
$7.5M
↓ 34.4%
Total Liabilities
$1.3M
↓ 4.3%
Long-term Debt
$4.7M
0.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 5/20/2026 | View on SEC |
| 424B5 | 5/18/2026 | View on SEC |
| 10-Q | 5/15/2026 | View on SEC |
| D | 2/25/2026 | View on SEC |
| 10-Q | 2/17/2026 | View on SEC |
| 424B3 | 12/30/2025 | View on SEC |
| EFFECT | 12/19/2025 | View on SEC |
| DEL AM | 12/16/2025 | View on SEC |
| S-3 | 12/15/2025 | View on SEC |
| 8-K | 11/26/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | NNVC |
| Company Name | NANOVIRICIDES, INC. |
| CIK | 1379006 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | NYSE |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0630 |
| State of Incorporation | DE |
| Phone | (203) 668-5580 |